CY1116592T1 - COGNITIVE THERAPY CONTAINING α5β1 COMPONENTS - Google Patents

COGNITIVE THERAPY CONTAINING α5β1 COMPONENTS

Info

Publication number
CY1116592T1
CY1116592T1 CY20151100696T CY151100696T CY1116592T1 CY 1116592 T1 CY1116592 T1 CY 1116592T1 CY 20151100696 T CY20151100696 T CY 20151100696T CY 151100696 T CY151100696 T CY 151100696T CY 1116592 T1 CY1116592 T1 CY 1116592T1
Authority
CY
Cyprus
Prior art keywords
components
relates
present
therapy containing
cognitive therapy
Prior art date
Application number
CY20151100696T
Other languages
Greek (el)
Inventor
Anan Chuntharapai
Greg Plowman
Marc Tessier-Lavigne
Yan Wu
Weilan Ye
Original Assignee
Genentech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07868188.9A external-priority patent/EP1989231B1/en
Application filed by Genentech, Inc. filed Critical Genentech, Inc.
Publication of CY1116592T1 publication Critical patent/CY1116592T1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με την χρήση ανταγωνιστών VEGF και ανταγωνιστών α5β1 για θεραπευτική αγωγή καρκίνου και αναστολή αγγειογένεσης και/ή αγγειακής διαπερατότητας, συμπεριλαμβανομένης αναστολής ανώμαλης αγγειογένεσης σε ασθένειες. Η παρούσα εφεύρεση σχετίζεται επίσης με την χρήση αγωνιστών VEGF και αγωνιστών α5β1 σε προαγωγή αγγειογένεσης και αγγειακής διαπερατότητας. Η παρούσα εφεύρεση σχετίζεται επίσης με νέα αντισώματα αντι-α5β1, συνθέσεις και κιτ που τα περιλαμβάνουν και με μεθόδους παρασκευής και χρήσης τους.The present invention relates to the use of VEGF antagonists and α5β1 antagonists for the treatment of cancer and inhibition of angiogenesis and / or vascular permeability, including inhibition of abnormal angiogenesis in diseases. The present invention also relates to the use of VEGF agonists and α5β1 agonists in promoting angiogenesis and vascular permeability. The present invention also relates to novel anti-α5β1 antibodies, compositions and kits comprising them and to methods for their preparation and use.

CY20151100696T 2006-03-21 2015-08-10 COGNITIVE THERAPY CONTAINING α5β1 COMPONENTS CY1116592T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US78470406A 2006-03-21 2006-03-21
US78533006A 2006-03-22 2006-03-22
US87174306A 2006-12-22 2006-12-22
EP07868188.9A EP1989231B1 (en) 2006-03-21 2007-03-21 Combinatorial therapy involving alpha5beta1 antagonists

Publications (1)

Publication Number Publication Date
CY1116592T1 true CY1116592T1 (en) 2017-03-15

Family

ID=58459758

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100696T CY1116592T1 (en) 2006-03-21 2015-08-10 COGNITIVE THERAPY CONTAINING α5β1 COMPONENTS

Country Status (1)

Country Link
CY (1) CY1116592T1 (en)

Similar Documents

Publication Publication Date Title
CY1117319T1 (en) TRICYCLIC AMIN PRODUCTS AS PROTEIN TYSINE MUSCLE INSPECTORS
CY1120866T1 (en) DNA-PK INHIBITORS
CY1124928T1 (en) PYRAZOLYL QUINOXALINE KINASE INHIBITORS
CY1116886T1 (en) C-MET ACCESSORIES
CY1120913T1 (en) MONOCLONIC ANTIBODIES AGAINST PROGASTRIN AND THEIR USE
CY1122707T1 (en) HETEROCYCLIC GLUTAMINASE INHIBITORS
CY1119591T1 (en) SPECIAL CONNECTION PROTEINS AND THEIR USES
CY1124412T1 (en) ANTI-DKK-1 ANTIBODIES
CY1117563T1 (en) HER3 PARTS AND USE OF THESE
CY1119454T1 (en) ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA
CY1121538T1 (en) MONOCLONIC ANTIBODIES AGAINST TISSUE FACTOR INHIBITOR (TFPI)
CY1119410T1 (en) OPTIMIZED monoclonal antibodies against the TFPI inhibitor (TFPI)
CY1118362T1 (en) Piperidinone Cyanide CGRP Receptor Competitors
CY1118874T1 (en) HUMANITIZED ANTIBODIES AGAINST LIV-1 AND USE FOR THERAPEUTIC TREATMENT
CY1119714T1 (en) SUSPENSION UNIONS
ECSP088835A (en) COMBINATORY THERAPY INVOLVING ALFA5BETA1 ANTAGONISTS
CY1116847T1 (en) FGF-R4 Receptor Specific Antagonists
CY1118143T1 (en) Heterocyclic compounds useful as PDK1 inhibitors
CY1118549T1 (en) USE OF ANTI-VEGF ANTIBODY IN COMBINATION WITH CHEMISTRY FOR TREATMENT OF BREAST CANCER
EA201001639A1 (en) COMPOSITIONS AND METHODS FOR THEIR PRODUCTION AND APPLICATION
CY1114272T1 (en) Substituted dihydropyrosolones for the therapeutic treatment of cardiovascular and hematological diseases
BR112015009752A2 (en) antibody / drug conjugates and methods of use
CY1120881T1 (en) 5-HT3 RECEPTOR COMPETITORS
EA201200218A1 (en) NEW BICYCLIC UREA COMPOUNDS
CY1112495T1 (en) CYTAROTOXIC FACTORS INCLUDING NEW TOMAIMYKIN PRODUCERS